ANIXA BIOSCIENCES, INC. Royalty Expense
ANIXA BIOSCIENCES, INC. (ANIX) reported Royalty Expense of $161.00 thousand for the 12-month period ending 2023-10-31, per its 10-K filed 2025-01-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2025-01-10
- ANIXA BIOSCIENCES, INC. royalty expense for the quarter ending 2023-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. royalty expense for the quarter ending 2023-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. royalty expense for the quarter ending 2023-04-30 was $161.00K.
- ANIXA BIOSCIENCES, INC. royalty expense for the quarter ending 2021-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. royalty expense for fiscal 2023 was $161.00K.
- ANIXA BIOSCIENCES, INC. royalty expense for fiscal 2021 was $385.00K.
- ANIXA BIOSCIENCES, INC. royalty expense for fiscal 2019 was $166.25K, a 78.36% decline from fiscal 2018.
- ANIXA BIOSCIENCES, INC. royalty expense for fiscal 2018 was $768.41K, a 634.93% increase from fiscal 2017.
| Period end | Royalty Expense 3 month | Royalty Expense 3 month as first filed | Royalty Expense 6 month | Royalty Expense 6 month as first filed | Royalty Expense 9 month | Royalty Expense 9 month as first filed | Royalty Expense 12 month | Royalty Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | $0.00 derived: sum of 2 quarters · filed 2025-01-10 | $161.00K derived: sum of 3 quarters · filed 2025-01-10 | $161.00K 10-K · filed 2025-01-10 | ||||
| 2023-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-09-06 | $161.00K derived: sum of 2 quarters · filed 2024-09-06 | $161.00K 10-Q · filed 2024-09-06 | |||||
| 2023-04-30 | $161.00K 10-Q · filed 2024-06-04 | $161.00K 10-Q · filed 2024-06-04 | ||||||
| 2021-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04 | $0.00 derived: sum of 2 quarters · filed 2023-01-04 | $0.00 derived: sum of 3 quarters · filed 2023-01-04 | $385.00K 10-K · filed 2023-01-04 | $385.00K 10-K · filed 2022-01-04 | |||
| 2021-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-09-09 | $0.00 derived: sum of 2 quarters · filed 2022-09-09 | $385.00K 10-Q · filed 2022-09-09 | $385.00K 10-Q · filed 2021-09-01 | ||||
| 2021-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-06-10 | $385.00K 10-Q · filed 2022-06-10 | $385.00K 10-Q · filed 2021-06-10 | |||||
| 2021-01-31 | $385.00K 10-Q · filed 2022-03-11 | $385.00K 10-Q · filed 2021-03-11 | ||||||
| 2019-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | $0.00 derived: sum of 2 quarters · filed 2021-01-07 | $166.25K derived: sum of 3 quarters · filed 2021-01-07 | $166.25K 10-K · filed 2021-01-07 | ||||
| 2019-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-09-06 | $166.25K derived: sum of 2 quarters · filed 2020-06-09 | $166.25K 10-Q · filed 2019-09-06 | |||||
| 2019-04-30 | $166.25K 10-Q · filed 2020-06-09 | $166.25K 10-Q · filed 2020-06-09 | ||||||
| 2018-10-31 | $1.23K derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $242.39K derived: sum of 2 quarters · filed 2020-01-09 | $743.06K derived: sum of 3 quarters · filed 2020-01-09 | $768.41K 10-K · filed 2020-01-09 | ||||
| 2018-07-31 | $241.16K 10-Q · filed 2019-09-06 | $741.83K derived: sum of 2 quarters · filed 2019-09-06 | $767.18K 10-Q · filed 2019-09-06 | $728.26K derived: sum of 4 quarters · filed 2019-09-06 | ||||
| 2018-04-30 | $500.67K 10-Q · filed 2019-06-12 | $526.02K 10-Q · filed 2019-06-12 | $487.11K derived: sum of 3 quarters · filed 2019-06-12 | $628.23K derived: sum of 4 quarters · filed 2019-06-12 | ||||
| 2018-01-31 | $25.35K 10-Q · filed 2019-03-13 | -$13.56K derived: sum of 2 quarters · filed 2019-03-13 | $127.56K derived: sum of 3 quarters · filed 2019-03-13 | $127.79K derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-10-31 | -$38.92K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | $102.21K derived: sum of 2 quarters · filed 2019-01-11 | $102.44K derived: sum of 3 quarters · filed 2019-01-11 | $104.56K 10-K · filed 2019-01-11 | $91.45K 10-K · filed 2018-01-09 | |||
| 2017-07-31 | $141.13K 10-Q · filed 2018-09-07 | $141.45K 10-Q · filed 2017-09-08 | $141.35K derived: sum of 2 quarters · filed 2018-09-07 | $143.47K 10-Q · filed 2018-09-07 | $141.45K 10-Q · filed 2017-09-08 | $192.94K derived: sum of 4 quarters · filed 2018-09-07 | ||
| 2017-04-30 | $225.00 10-Q · filed 2018-06-11 | $2.35K 10-Q · filed 2018-06-11 | $51.82K derived: sum of 3 quarters · filed 2018-06-11 | $113.54K derived: sum of 4 quarters · filed 2018-06-11 | ||||
| 2017-01-31 | $2.12K 10-Q · filed 2018-03-09 | $51.59K derived: sum of 2 quarters · filed 2018-03-09 | $113.31K derived: sum of 3 quarters · filed 2018-03-09 | |||||
| 2016-10-31 | $49.47K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09 | $111.19K derived: sum of 2 quarters · filed 2018-01-09 | $111.19K 10-K · filed 2018-01-09 | |||||
| 2016-07-31 | $61.72K 10-Q · filed 2017-09-08 | $61.72K 10-Q · filed 2017-09-08 | ||||||
| 2015-10-31 | -$5.19K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $43.73K derived: sum of 2 quarters · filed 2016-12-08 | $58.79K derived: sum of 3 quarters · filed 2016-12-08 | $147.67K 10-K · filed 2016-12-08 | ||||
| 2015-07-31 | $48.92K 10-Q · filed 2016-08-19 | $63.98K derived: sum of 2 quarters · filed 2016-08-19 | $152.86K 10-Q · filed 2016-08-19 | $1.10M derived: sum of 4 quarters · filed 2016-08-19 | ||||
| 2015-04-30 | $15.07K 10-Q · filed 2016-05-20 | $103.94K 10-Q · filed 2016-05-20 | $1.05M derived: sum of 3 quarters · filed 2016-05-20 | $1.05M derived: sum of 4 quarters · filed 2016-05-20 | ||||
| 2015-01-31 | $88.88K 10-Q · filed 2016-02-19 | $1.04M derived: sum of 2 quarters · filed 2016-02-19 | $1.04M derived: sum of 3 quarters · filed 2016-02-19 | $1.50M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-10-31 | $947.57K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $947.57K derived: sum of 2 quarters · filed 2015-12-23 | $1.41M derived: sum of 3 quarters · filed 2015-12-23 | $1.41M 10-K · filed 2015-12-23 | ||||
| 2014-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $465.10K derived: sum of 2 quarters · filed 2015-08-18 | $465.10K 10-Q · filed 2015-08-18 | |||||
| 2014-04-30 | $465.10K 10-Q · filed 2015-05-22 | $465.10K 10-Q · filed 2015-05-22 | ||||||
| 2013-10-31 | $207.74K 10-K · filed 2015-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |